ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.083,05
-2,25%
S&P 500
5.464,76
-1,04%
Dow Jones
40.307,98
-1,31%
Euro vs US Dollar
1,07857
-0,35%
Bitcoin
62.873,31
-2,68%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. DexCom Inc (DXCM)

  7. DexCom Inc (DXCM) News

DXCM

DexCom (DXCM)

DexCom Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DXCM
DatumZeitQuelleÜberschriftSymbolFirma
31/07/202422h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DXCMDexCom Inc
29/07/202415h00Business WireTandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health CanadaNASDAQ:DXCMDexCom Inc
29/07/202415h00Business WireTandem Diabetes Care et Dexcom annoncent que la pompe à insuline t:slim X2 compatible avec le système de SGC Dexcom G7 est autorisée à la vente par Santé CanadaNASDAQ:DXCMDexCom Inc
28/07/202418h14PR Newswire (US)Edelson Lechtzin LLP Announces Investigation Dexcom, Inc. (NASDAQ: DXCM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the FirmNASDAQ:DXCMDexCom Inc
26/07/202411h57IH Market NewsDexcom Shares Drop 37% on Weak Revenue and Forecast; Coursera Rises 24% After Beating Q2 Revenue EstimatesNASDAQ:DXCMDexCom Inc
25/07/202423h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DXCMDexCom Inc
25/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXCMDexCom Inc
25/07/202422h03Business WireDexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase ProgramNASDAQ:DXCMDexCom Inc
25/07/202412h21IH Market NewsU.S. Index Futures Mixed After Tech Sell-Off, Oil Prices Drop on Weak China Demand and Ceasefire ExpectationsNASDAQ:DXCMDexCom Inc
27/06/202414h30Business WireDexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.NASDAQ:DXCMDexCom Inc
20/06/202413h15Business WireDexcom Expands AID Partnership Into The NetherlandsNASDAQ:DXCMDexCom Inc
20/06/202412h05Business WireDexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
19/06/202401h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
18/06/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DXCMDexCom Inc
17/06/202422h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DXCMDexCom Inc
14/06/202416h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DXCMDexCom Inc
12/06/202400h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
12/06/202400h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
12/06/202400h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
05/06/202412h00Business WireDexcom G7 Now Connects Directly to Apple Watch in the U.S.NASDAQ:DXCMDexCom Inc
04/06/202416h16Business WireDexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
04/06/202413h00Business WireDexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
31/05/202423h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
31/05/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DXCMDexCom Inc
29/05/202422h59Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:DXCMDexCom Inc
29/05/202414h30Business WireDexcom Announces Upcoming Conference PresentationNASDAQ:DXCMDexCom Inc
29/05/202414h30Business WireTandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGMNASDAQ:DXCMDexCom Inc
24/05/202423h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
24/05/202423h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
24/05/202423h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
 Showing the most relevant articles for your search:NASDAQ:DXCM

Kürzlich von Ihnen besucht

NASDAQ
AAPL
Apple
DBI
DAX
DAX
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
TG
DBK
Deutsche Bank
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
TG
NOV
Novo Nordisk
TG
LHA
Deutsche Lufthansa
FX
EURJPY
Euro vs Yen
TG
BAS
BASF
CCOM
US100
US Tech 100
TG
ALV
Allianz
CCOM
SILVER
SILVER
DBI
MDAX
MDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten